19 results
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:56am
in Israel, pursuant to which Wolc will be the exclusive supplier of any approved pharmaceutical drug products of the Company in Israel.
Although we
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:55am
an exclusive distribution agreement in Israel, pursuant to which Wolc will be the exclusive supplier of any approved pharmaceutical drug products
POS AM
RAPH
Raphael Pharmaceutical Inc.
4 May 23
Prospectus update (post-effective amendment)
4:01pm
with Wolc, the parties are expected to negotiate an exclusive distribution agreement in Israel, pursuant to which Wolc will be the exclusive supplier
POS AM
RAPH
Raphael Pharmaceutical Inc.
2 May 23
Prospectus update (post-effective amendment)
4:02pm
with Wolc, the parties are expected to negotiate an exclusive distribution agreement in Israel, pursuant to which Wolc will be the exclusive supplier of any
POS AM
4s7eu0ph cj
26 May 22
Prospectus update (post-effective amendment)
9:28am
10-12G/A
vkig0woil0f
23 Sep 21
Registration of securities (amended)
6:19am
10-12G/A
rnz40zcvff 77glqvto
2 Sep 21
Registration of securities (amended)
5:28pm
10-12G
jx5ny8
29 Jul 21
Registration of securities
12:00am
10-12G/A
n5iz5caes
2 Jul 21
Registration of securities (amended)
4:15pm
10-12G
rlklo31np63ups0tkv
14 May 21
Registration of securities
5:27pm
- Prev
- 1
- Next